This month we’ll discuss the 21st Century Cures Act – a $6.3 billion, nearly 1,000-page, comprehensive legislation package that passed the U.S. House and Senate in late December 2016. 21st Century Cures overhauls the way drugs and devices will be coming to market; the legislation offers grant funding to states to help fight the opioid epidemic and addresses mental health laws and resources. It also places a big emphasis on research funding – especially for cancer and neurodegenerative diseases – and patient rights. All of these factors are expected to change the research-to-commercialization pathway. Please join us as we learn more about the act and its impact on patients, regulators, and large and small companies.
Jeanne Haggerty, Senior Vice President, Federal Government Relations
Lynn Tyler, Partner
Barnes & Thornburg LLP
Indiana Health Industry Forum
The Indiana Health Industry Forum and Barnes & Thornburg LLP partner to present a monthly seminar series on critical issues in life science. Each month, at lunch, a policymaker or a panel in the field of life science will be available to answer questions concerning the major challenges and opportunities in the life science industry. We hope you will join us.
For more information on upcoming programs, please visit www.ihif.org/pages/lifescience
Follow us on Twitter @IHIF1 #LifeScienceLunch @BTLawNews